Geneith’s Camosunate and World Malaria Day
Among
pharmaceutical companies with research and development initiatives in Nigeria today
is Geneith Pharmaceuticals. Incorporated in the year 2000 as a private limited
liability company, the main business of the company is distribution of drugs
and pharmaceuticals with standards above the bar, in the quest for value
additions to the health and quality of life of Nigerians. The Company’s
products, including Camosunate ACT Anti-Malarial, its flagship brand, are all
NAFDAC registered and currently sourced from various overseas pharmaceutical
Companies with GMP certification. Geneith’s impacts and contributions has been
asserted and confirmed with several awards such as Best Malaria Management Drug
Award conferred on Camosunate by African Products Award 2002, and West African
Best Malaria Award, also conferred on Camosunate by the West African Direct
marketing Award in 2007.
In this
brief Chat, The MD/CEO of the Geneith Pharmaceuticals Mr. Emmanuel Umenwa sheds
more light on Geneith, Camosunate and World Malaria Day.
Tell us
about Camosunate anti-malarial drug from Geneith?
Camosunate is just one of several other quality brands
in our product portfolio. It comes in 4 age ranges, “Camosunate Adult” (above
14yrs), “Camosunate Junior” (7-13 yrs), our flagship “Camosunate 1-6 yrs” and “Camosunate“less
than 1 year”. This makes the product available across the whole family age
ranges conforming with the WHO guideline
for each of the components.
What special qualities distinguish Camosunate from the myriad of other anti-malarial drugs in Nigerian market today?
Camosunate is an ACT containing Artesunate and Amodiaquine.
This is a front line recommendation by WHO. Camosunate
adult and Junior comes in tablets. The Tablets are coated to mask the bitter
taste of the Amodiaquine. This enhances overall compliance. The dose ranges for
children and neonates are formulated in easily dissolvable granules. This
confers to it a unique dissolution and absorption profile. The Paediatric
preparations are also vanilla flavoured, this suppresses the bitter after taste
associated with quinine based products. The children products are packaged in
unit dose sachets. This eliminates storage and stability challenges.
Degradation by hydrolysis is eliminated as there is no need to store water
reconstituted products. Above all the product is affordable.
The World
Malaria Day is around the corner, in what ways is Camosunate creating awareness
on how we can fight malaria?
We are reaching out
to the public via our customer data base and various social media. We are
running a malarial awareness programmed on all our social media platforms
(Website, Facebook and Twitter). As a
company committed to the well being of the populace Geneith is providing information on malaria
prevention using these media. For the
week leading to this day, hospitals and pharmacies get special discount on all
our anti-malarial products.
Does Camosunate have any side effects?
Does Camosunate have any side effects?
Well like every drug, Camosunate has side effects, even
though they are highly minimized and controlled and they are mostly transient
and manageable. The most common side effect is the lethargic effect due to
hypoglycemia (low blood sugar). This is usually taken care of by taking
Camosunate with a sugar rich medium, like glucose drink or starchy meals.
Camosunate does not itch. This lethargic side effect is predominantly observed
in adults. The adult doses are taken twice daily to further reduce the side
effects.
Who should not take Camosunate?
Camosunate as I mentioned earlier is for the whole family
and the safety margin is quite commendable. In a recent study carried out in Benin, Dr. U U Uyagu and Proffessor Omagborale
both of the University
of Benin Teaching Hospital
confirmed the efficacy and safety of Camosunate. However we still advice that
patients consult their doctors in special circumstances such as pregnancy.
The national policy on malaria treatment stipulates Artesimisin combination therapy. Is Camosunate compliant with this stipulation?
The national policy on malaria treatment stipulates Artesimisin combination therapy. Is Camosunate compliant with this stipulation?
Yes, Camosunate
is an Artemisin Combining Therapy (ACT) antimalarial drug containing Artesunate
and Amodiaquine. This is a front line recommendation by World Health
Organization, (WHO).
There are reports of malaria parasite resistance to ACT drugs, with some people returning to chloroquine. How does this relate to Camosunate?
Camosunate has a
unique advantage of having a relatively long half life of above 30 days. This
longer lasting effect provides for longer protection of Camosunate and as such
leaves little room for relapse which usually leads to resistance.
Tell us about Geneith’s CSR initiatives with
Camosunate?
Corporate Social responsibly (CSR) is one policy very dear
to our heart at GENEITH PHARMACEUTICALS. We have periodically identified with
the hopes and aspirations of several medical associations with generous
donations of our Camosunate anti-malarial products. We have sponsored
educational activities and created awareness in our immediate environment. We
provide support for annual Inter-house sports activities in secondary and
primary schools in our immediate environment. Researches for public benefits
have been sponsored by our company.
What other OTC or ethical drugs are marketed by GENEITH?
In our product
portfolio are several high quality products spanning various genres of drugs including
but not limited to antibiotics (Nosclav ranges), (Amodiaquine/clavulanic acid)
including the Children friendly Nosclav DT, Pulmocef (Ceftriaxone), Antimalarial
(Camosunate, Coatal, Gilanox), Analgesics (Tramed caps and injection), Tribact
cream, Irondex among other products.
Ebola Virus
is ravaging the West African countries for the past one month, is GENEITH
concerned?
As a responsible cooperate organization, we are concerned
about this current challenges of ebola virus. Even though we have no antiviral
products per say but by interactions with our customers, we preach proper
hygiene which limits person to person transmission.
Tweet